Multidisciplinary Collaborative Integrated Management of Increasingly Prominent HIV Complications in the Post-cART Era

Overview

Journal HIV Med

Publisher Wiley

Specialty Infectious Diseases

Date 2020 Dec 28

PMID 33369030

Citations 1

Authors

L Lin

T S Li

Affiliations

Soon will be listed here.

Abstract

Objectives: With the prolonged survival time of AIDS patients, complications of various systems and organs of HIV infection are increasingly prominent. These diseases have become the major factors influencing the quality of life and prognosis of HIV-infected persons, and multidisciplinary cooperation treatment is urgently needed.

Methods: The Chinese HIV/AIDS Clinical Trial Network has conducted a series of multicentre clinical cohort studies over the past 16 years, in which studies related to people living with HIV systemic complications. Based on the results of previous studies, this review establishes the complications of Chinese people living with HIV after long-term cART.

Results: HIV's direct damage to human cells, chronic abnormal inflammatory activation after HIV infection, long-term drug side effects caused by cART and persistent reservoirs cause systemic complications in people living with HIV. We summarised the clinical characteristics of the complications of HIV infection in China from the aspects of the liver, cardiovascular, the nervous system, the kidney, bone metabolism, blood glucose, and lipid metabolism.

Conclusions: The management of the complications of HIV infection is a major link in improving the survival treatment and prognosis of patients in the future. The joint participation of doctors from different departments of general hospitals in the management of comorbidities is the main theme for future improvement of quality of life and prognosis for people living with HIV.

Citing Articles

Integrated Care as a Model for Interprofessional Disease Management and the Benefits for People Living with HIV/AIDS.

Beichler H, Grabovac I, Dorner T Int J Environ Res Public Health. 2023; 20(4).

PMID: 36834069 PMC: 9965658. DOI: 10.3390/ijerph20043374.

References

Gu L, Han Y, Li Y, Zhu T, Song X, Huang Y . Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China. PLoS One. 2015; 10(8):e0134539. PMC: 4543549. DOI: 10.1371/journal.pone.0134539. View

Friis-Moller N, Reiss P, Sabin C, Weber R, Monforte A, El-Sadr W . Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007; 356(17):1723-35. DOI: 10.1056/NEJMoa062744. View

Bruun J, Lihn A, Verdich C, Pedersen S, Toubro S, Astrup A . Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab. 2003; 285(3):E527-33. DOI: 10.1152/ajpendo.00110.2003. View

Hsieh E, Fraenkel L, Xia W, Hu Y, Han Y, Insogna K . Increased bone resorption during tenofovir plus lopinavir/ritonavir therapy in Chinese individuals with HIV. Osteoporos Int. 2014; 26(3):1035-44. PMC: 4334679. DOI: 10.1007/s00198-014-2874-3. View

Su T, Wit F, Caan M, Schouten J, Prins M, Geurtsen G . White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy. AIDS. 2016; 30(15):2329-39. DOI: 10.1097/QAD.0000000000001133. View

Gardner L, Holmberg S, Williamson J, Szczech L, Carpenter C, Rompalo A . Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr. 2003; 32(2):203-9. DOI: 10.1097/00126334-200302010-00013. View

Li Y, Xie J, Han Y, Wang H, Lv W, Guo F . Combination Antiretroviral Therapy Is Associated With Reduction in Liver Fibrosis Scores in HIV-1-Infected Subjects. Medicine (Baltimore). 2016; 95(5):e2660. PMC: 4748910. DOI: 10.1097/MD.0000000000002660. View

Chow F, Wang H, Li Y, Mehta N, Hu Y, Han Y . Cerebral Vasoreactivity Evaluated by the Breath-Holding Challenge Correlates With Performance on a Cognitive Screening Test in Persons Living With Treated HIV Infection in China. J Acquir Immune Defic Syndr. 2018; 79(3):e101-e104. PMC: 7384372. DOI: 10.1097/QAI.0000000000001805. View

Gallant J, Staszewski S, Pozniak A, DeJesus E, Suleiman J, Miller M . Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA. 2004; 292(2):191-201. DOI: 10.1001/jama.292.2.191. View

10.

Luo L, Ye Y, Liu Z, Zuo L, Li Y, Han Y . Assessment of cardiac diastolic dysfunction in HIV-infected people without cardiovascular symptoms in China. Int J STD AIDS. 2011; 21(12):814-8. DOI: 10.1258/ijsa.2010.010168. View

11.

Guo F, Hsieh E, Lv W, Han Y, Xie J, Li Y . Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease. BMC Infect Dis. 2017; 17(1):287. PMC: 5397830. DOI: 10.1186/s12879-017-2358-0. View

12.

Cao Y, Han Y, Xie J, Cui Q, Zhang L, Li Y . Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study. BMC Infect Dis. 2013; 13:301. PMC: 3707768. DOI: 10.1186/1471-2334-13-301. View

13.

Yao J, Yu W, Li T, Luo L, Lin Q, Tian J . The pilot study of DXA assessment in chinese HIV-infected men with clinical lipodystrophy. J Clin Densitom. 2010; 14(1):58-62. DOI: 10.1016/j.jocd.2010.08.002. View

14.

Chow F, Li Y, Hu Y, Chan J, Wang H, Xu W . Relationship Between HIV Infection, Antiretroviral Therapy, Inflammatory Markers, and Cerebrovascular Endothelial Function Among Adults in Urban China. J Acquir Immune Defic Syndr. 2016; 74(3):339-346. PMC: 5303185. DOI: 10.1097/QAI.0000000000001254. View

15.

Ye Y, Zeng Y, Li X, Zhang S, Fang Q, Luo L . HIV infection: an independent risk factor of peripheral arterial disease. J Acquir Immune Defic Syndr. 2010; 53(2):276-8. DOI: 10.1097/QAI.0b013e3181ba1c31. View

16.

Seider T, Gongvatana A, Woods A, Chen H, Porges E, Cummings T . Age exacerbates HIV-associated white matter abnormalities. J Neurovirol. 2015; 22(2):201-12. PMC: 4783252. DOI: 10.1007/s13365-015-0386-3. View

17.

Foca E, Motta D, Borderi M, Gotti D, Albini L, Calabresi A . Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. BMC Infect Dis. 2012; 12:38. PMC: 3296645. DOI: 10.1186/1471-2334-12-38. View

18.

Wang H, Li Y, Zhang C, Han Y, Zhang X, Zhu T . Immunological and virological responses to cART in HIV/HBV co-infected patients from a multicenter cohort. AIDS. 2012; 26(14):1755-63. DOI: 10.1097/QAD.0b013e328355ced2. View

19.

Pozzan G, Pagliari C, Tuon F, Takakura C, Kauffman M, Duarte M . Diffuse-regressive alterations and apoptosis of myocytes: possible causes of myocardial dysfunction in HIV-related cardiomyopathy. Int J Cardiol. 2008; 132(1):90-5. DOI: 10.1016/j.ijcard.2007.10.057. View

20.

Guo F, Cheng X, Hsieh E, Du X, Fu Q, Peng W . Prospective plasma efavirenz concentration assessment in Chinese HIV-infected adults enrolled in a large multicentre study. HIV Med. 2018; . PMC: 6538474. DOI: 10.1111/hiv.12607. View